Wilson Martin 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Feb 13, 2025
Insider Transaction Report
Form 4
Wilson Martin
General Counsel
Transactions
- Award
Common Stock
2025-02-11+90,358→ 153,918 total - Award
Stock Option (Right to Buy)
2025-02-11+134,642→ 134,642 totalExercise: $9.88Exp: 2035-02-11→ Common Stock (134,642 underlying)
Footnotes (2)
- [F1]Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.
- [F2]This option represents a right to purchase a total of 134,642 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.